Free Trial

Avidity Biosciences (RNA) Insider Trading & Ownership

Avidity Biosciences logo
$43.65 +0.40 (+0.92%)
(As of 11/20/2024 ET)

Avidity Biosciences (NASDAQ:RNA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.68%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$29.96 M
Get RNA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avidity Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RNA Insider Buying and Selling by Quarter

Avidity Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/19/2024Arthur A LevinDirectorSell3,323$42.12$139,964.76  
11/18/2024Teresa MccarthyInsiderSell25,000$41.14$1,028,500.00  
10/21/2024Arthur A LevinDirectorSell5,000$46.63$233,150.00  
10/16/2024Teresa MccarthyInsiderSell25,000$48.52$1,213,000.00  
10/7/2024Tamar ThompsonDirectorSell30,000$44.98$1,349,400.00  
9/23/2024Michael F MacleanCFOSell11,510$44.00$506,440.00  
9/23/2024Sarah BoyceCEOSell32,880$44.00$1,446,720.00  
9/23/2024Teresa MccarthyInsiderSell13,153$44.00$578,732.00  
9/19/2024Arthur A LevinDirectorSell5,000$45.73$228,650.00  
8/19/2024Arthur A LevinDirectorSell5,000$45.19$225,950.00  
8/6/2024Sarah BoyceCEOSell28,000$43.35$1,213,800.00  
7/19/2024Arthur A LevinDirectorSell5,000$45.01$225,050.00  
7/9/2024Sarah BoyceCEOSell28,000$39.93$1,118,040.00  
6/20/2024Arthur A LevinDirectorSell5,000$37.59$187,950.00  
6/13/2024Sarah BoyceCEOSell164,233$40.08$6,582,458.64  
6/12/2024Arthur A LevinDirectorSell40,000$35.07$1,402,800.00  
6/12/2024Michael F MacleanCFOSell104,245$35.72$3,723,631.40  
6/4/2024Sarah BoyceCEOSell28,000$27.42$767,760.00  
5/20/2024Arthur A LevinDirectorSell5,000$29.90$149,500.00  
5/14/2024Michael F MacleanCFOSell75,000$28.28$2,121,000.00  
5/7/2024Sarah BoyceCEOSell28,000$25.54$715,120.00  
4/19/2024Arthur A LevinDirectorSell5,000$22.82$114,100.00  
4/3/2024Arthur A LevinDirectorSell20,000$27.11$542,200.00  
3/13/2024Michael F MacleanCFOSell40,000$24.52$980,800.00  
3/12/2024Arthur A LevinDirectorSell27,641$22.03$608,931.23  
3/12/2024Sarah BoyceCEOSell28,000$22.63$633,640.00  
3/8/2024Sarah BoyceCEOSell84,000$21.39$1,796,760.00  
1/22/2024Arthur A LevinDirectorSell1,859$10.13$18,831.67  
1/22/2024Michael F MacleanCFOSell1,616$10.13$16,370.08  
1/22/2024Sarah BoyceCEOSell5,092$10.13$51,581.96  
1/22/2024W. Michael FlanaganInsiderSell4,129$10.13$41,826.77  
(Data available from 1/1/2013 forward)

RNA Insider Trading Activity - Frequently Asked Questions

3.68% of Avidity Biosciences stock is owned by insiders. Learn more on RNA's insider holdings.

The following insiders have sold RNA shares in the last 24 months: Arthur A Levin ($4,533,677.66), Michael F Maclean ($7,348,241.48), Sarah Boyce ($14,425,865.06), Tamar Thompson ($1,349,400.00), Teresa Mccarthy ($2,820,232.00), and W. Michael Flanagan ($41,826.77).

Insiders have sold a total of 907,802 Avidity Biosciences shares in the last 24 months for a total of $30,519,242.97 sold.

Avidity Biosciences Key Executives



This page (NASDAQ:RNA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners